Total Payments
$27,006
2024 Payments
$562.50
Companies
15
Transactions
45
Medicare Patients
616
Medicare Billing
$146,469
Payment Breakdown by Category
Other$25,000 (92.6%)
Food & Beverage$1,319 (4.9%)
Consulting$562.50 (2.1%)
Travel$123.73 (0.5%)
Education$1.18 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $25,000 | 2 | 92.6% |
| Food and Beverage | $1,319 | 38 | 4.9% |
| Consulting Fee | $562.50 | 1 | 2.1% |
| Travel and Lodging | $123.73 | 2 | 0.5% |
| Education | $1.18 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $25,087 | 3 | $0 (2019) |
| Boston Scientific Corporation | $824.26 | 9 | $0 (2024) |
| Abbott Laboratories | $530.27 | 6 | $0 (2019) |
| GE HEALTHCARE | $114.59 | 3 | $0 (2020) |
| Merz North America, Inc. | $100.00 | 1 | $0 (2019) |
| Allergan, Inc. | $89.39 | 6 | $0 (2020) |
| ACADIA Pharmaceuticals Inc | $68.02 | 4 | $0 (2020) |
| Lilly USA, LLC | $48.20 | 3 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $35.84 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $32.68 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $562.50 | 1 | Boston Scientific Corporation ($562.50) |
| 2023 | $148.70 | 1 | Boston Scientific Corporation ($148.70) |
| 2022 | $1.18 | 2 | Travere Therapeutics, Inc. ($1.18) |
| 2021 | $59.13 | 4 | Lilly USA, LLC ($21.95) |
| 2020 | $356.54 | 19 | Allergan, Inc. ($89.39) |
| 2019 | $19,253 | 13 | Medtronic USA, Inc. ($18,750) |
| 2018 | $288.83 | 3 | Abbott Laboratories ($288.83) |
| 2017 | $6,337 | 2 | Medtronic USA, Inc. ($6,337) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/26/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $562.50 | General |
| Category: General - DBS_NMD | ||||||
| 04/13/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $148.70 | General |
| Category: General - DBS_NMD | ||||||
| 06/13/2022 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 06/13/2022 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $0.35 | General |
| Category: Hepatology | ||||||
| 12/27/2021 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/20/2021 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2021 | Sunovion Pharmaceuticals Inc. | KYNMOBI (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: CNS | ||||||
| 01/06/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Neuroscience | ||||||
| 12/08/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/04/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Neuroscience | ||||||
| 10/29/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/06/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: HYPERHYDROSIS | ||||||
| 07/01/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: HYPERHYDROSIS | ||||||
| 03/13/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Central Nervous System | ||||||
| 03/13/2020 | Boston Scientific Corporation | VERCISE (Device) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: DBS | ||||||
| 03/10/2020 | Boston Scientific Corporation | VERCISE (Device) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: DBS | ||||||
| 03/08/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/03/2020 | Lilly USA, LLC | LIVALO (Drug), EMGALITY | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Cardiovascular | ||||||
| 02/28/2020 | Kyowa Kirin, Inc. | NOURIANZ (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: ADENOSINE A2A RECEPTORS | ||||||
| 02/27/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/21/2020 | Boston Scientific Corporation | VERCISE (Device) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: DBS | ||||||
| 02/14/2020 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: PD | ||||||
| 02/06/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/10/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/07/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: HYPERHYDROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 188 | 7,913 | $314,392 | $68,358 |
| 2022 | 3 | 139 | 229 | $116,710 | $30,410 |
| 2021 | 3 | 140 | 206 | $97,461 | $27,778 |
| 2020 | 6 | 149 | 183 | $79,415 | $19,922 |
Total Patients
616
Total Services
8,531
Medicare Billing
$146,469
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 20 | 7,660 | $189,400 | $37,979 | 20.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 82 | 138 | $74,934 | $18,720 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 64 | $23,616 | $5,693 | 24.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $10,785 | $2,385 | 22.1% |
| 64611 | Injection of chemical for paralysis of salivary glands on both sides of mouth | Office | 2023 | 11 | 22 | $9,020 | $2,123 | 23.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 11 | 14 | $6,637 | $1,459 | 22.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 80 | 158 | $85,685 | $22,379 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 57 | $20,959 | $5,426 | 25.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $10,066 | $2,605 | 25.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 56 | 98 | $48,984 | $13,789 | 28.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 52 | 76 | $26,714 | $8,002 | 30.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 32 | 32 | $21,763 | $5,986 | 27.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 39 | 55 | $24,695 | $6,243 | 25.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 45 | 63 | $21,042 | $5,556 | 26.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 24 | 24 | $15,264 | $3,602 | 23.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $8,602 | $1,952 | 22.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 13 | 13 | $5,434 | $1,385 | 25.5% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 11 | 11 | $4,378 | $1,184 | 27.0% |
About Dr. David Coughlin, M.D
Dr. David Coughlin, M.D is a Neurology healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2012. The National Provider Identifier (NPI) number assigned to this provider is 1740543784.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Coughlin, M.D has received a total of $27,006 in payments from pharmaceutical and medical device companies, with $562.50 received in 2024. These payments were reported across 45 transactions from 15 companies. The most common payment nature is "Grant" ($25,000).
As a Medicare-enrolled provider, Coughlin has provided services to 616 Medicare beneficiaries, totaling 8,531 services with total Medicare billing of $146,469. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Internal Medicine, Neurology
- Location San Diego, CA
- Active Since 06/22/2012
- Last Updated 02/17/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740543784
Products in Payments
- ACTIVA (Device) $25,087
- Infinity DBS Pulse Generators (Device) $406.54
- Proclaim Family of SCS IPGs (Device) $123.73
- VERCISE (Device) $104.39
- XEOMIN (Biological) $100.00
- BOTOX (Biological) $89.39
- NUPLAZID (Drug) $68.02
- INGREZZA (Drug) $35.84
- EMGALITY (Drug) $35.66
- GOCOVRI (Drug) $23.45
- NOURIANZ (Drug) $21.51
- AUSTEDO (Drug) $18.99
- KESIMPTA (Drug) $17.37
- MAYZENT (Drug) $15.31
- LIVALO (Drug) $12.54
- KYNMOBI (Drug) $11.14
- GENERAL PAIN MANAGEMENT (Device) $8.67
- Cholbam (Drug) $1.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in San Diego
Dr. Revere Kinkel, M.d, M.D
Neurology — Payments: $432,113
Neurology $432,113
Dr. Hossein Ansari, M.d, M.D
Neurology — Payments: $431,759
Neurology $431,759
Nathaniel Schuster, M.d, M.D
Neurology — Payments: $313,162
Neurology $313,162
Dr. Monali Patel, M.d, M.D
Neurology — Payments: $251,383
Neurology $251,383
Jennifer Graves, Md, MD
Neurology — Payments: $138,828
Neurology $138,828
Dr. Jose Soria-Lopez, Md, MD
Neurology — Payments: $108,135
Neurology $108,135